Comparison of Nonalbuminuric and Albuminuric Diabetic Kidney Disease Among Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis

被引:17
作者
Shi, Shaomin [1 ,2 ]
Ni, Lihua [1 ]
Gao, Ling [2 ]
Wu, Xiaoyan [1 ]
机构
[1] Zhongnan Hosp Wuhan Univ, Dept Nephrol, Wuhan, Peoples R China
[2] Affiliated Hosp Hubei Univ Arts & Sci, Xiangyang Cent Hosp, Xiangyang, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2022年 / 13卷
关键词
characteristics; pathology; prognosis; systematic review; nonalbuminuric DKD; GLOMERULAR-FILTRATION-RATE; ALL-CAUSE MORTALITY; RENAL-INSUFFICIENCY; RISK-FACTORS; NEPHROPATHY; IMPAIRMENT; RETINOPATHY; PREVALENCE; DECLINE; ABSENCE;
D O I
10.3389/fendo.2022.871272
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Diabetic kidney disease (DKD) is one of most common complications of diabetes. Recently, the classical phenotype of DKD, which is characterized by albuminuria preceding renal insufficiency, has been challenged since a subset of diabetic patients with renal insufficiency but without albuminuria has been increasingly reported. However, the available evidence is inconsistent. Thus, the present systematic review will assess and summarize the available data regarding nonalbuminuric diabetic kidney disease (NADKD). Methods: PubMed, Embase, and Cochrane were searched for clinical trials related to NADKD. The results were limited to full-text articles published in English, without restrictions on the publication time. The quality of clinical trials was appraised, and the data were extracted. Meta-analysis was conducted using a random-effects model. Descriptive analysis was performed if the data were insufficient. Results: A final total of 31 articles were included in this review. The meta-analysis of 18 studies showed that compared with albuminuric DKD, patients with NADKD were older (MD = 1.04 years old, 95% CI [0.52, 1.57], p < 0.05); were more often women (Male RR = 0.74, 95% CI [0.68, 0.81], p < 0.05); had shorter diabetes duration (MD = -2.9 years, 95% CI [-3.63, -2.18], p < 0.05), lower HbA1c levels (MD = -0.34%, 95% CI [-0.42, -0.25], p < 0.05), and lower blood pressure (systolic blood pressure MD = -6.21 mmHg, 95% CI [-9.41, -3.0], p < 0.05; diastolic blood pressure MD = -1.27 mmHg, 95% CI [-2.15, 4.0], p < 0.05); less frequently experienced diabetic retinopathy (RR = 0.58, 95% CI [0.51, 0.67], p < 0.05); and less frequently used renin-angiotensin-aldosterone system (RAAS) inhibitors. The underlying pathology of NADKD might be different from that of the classic phenotype of DKD, which is associated with more advanced tubulointerstitial and vascular lesions but mild typical glomerular lesions. The annual estimated glomerular filtration rate decline tended to be lower in patients with NADKD than in those with albuminuric DKD. The risk for cardiovascular disease, end-stage renal disease, and all-cause death was lower for patients with NADKD than patients with albuminuric DKD. Conclusions: The prevalence of NADKD has increased in recent decades, and its characteristics, pathology, and prognosis are different from those of albuminuric DKD; thus, diagnosis and treatment strategies should be different. More attention should be given to this phenotype.
引用
收藏
页数:11
相关论文
共 54 条
  • [1] Ongoing treatment with renin-angiotensin-aldosterone-blocking agents does not predict normoalbuminuric renal impairment in a general type 2 diabetes population
    Afghahi, Hanri
    Miftaraj, Mervete
    Svensson, Ann-Marie
    Hadimeri, Henrik
    Gudbjornsdottir, Soffia
    Eliasson, Bjorn
    Svensson, Maria K.
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2013, 27 (03) : 229 - 234
  • [2] Risk factors for the development of albuminuria and renal impairment in type 2 diabetes-the Swedish National Diabetes Register (NDR)
    Afghahi, Henri
    Cederholm, Jan
    Eliasson, Bjorn
    Zethelius, Bjorn
    Gudbjornsdottir, Soffia
    Hadimeri, Henrik
    Svensson, Maria K.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (04) : 1236 - 1243
  • [3] Long-term retinal, renal and cardiovascular outcomes in diabetic chronic kidney disease without proteinuria
    Agarwal, Rajiv
    Debella, Yalew T.
    Giduma, Habtamu D.
    Light, Robert P.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (01) : 310 - 317
  • [4] The Clinical Characteristics of Normoalbuminuric Renal Insufficiency in Korean Type 2 Diabetic Patients: A Possible Early Stage Renal Complication
    An, Jee Hyun
    Cho, Young Min
    Yu, Hyeong Gon
    Jang, Hak Chul
    Park, Kyong Soo
    Kim, Seong Yeon
    Lee, Hong Kye
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2009, 24 : S75 - S81
  • [5] Polymorphisms of the protein kinase C-β gene (PRKCB1) accelerate kidney disease in type 2 diabetes without overt proteinuria
    Araki, SI
    Haneda, M
    Sugimoto, T
    Isono, M
    Isshiki, K
    Kashiwagi, A
    Koya, D
    [J]. DIABETES CARE, 2006, 29 (04) : 864 - 868
  • [6] Poor Glycemic Control in Diabetes and the Risk of Incident Chronic Kidney Disease Even in the Absence of Albuminuria and Retinopathy Atherosclerosis Risk in Communities (ARIC) Study
    Bash, Lori D.
    Selvin, Elizabeth
    Steffes, Michael
    Coresh, Josef
    Astor, Brad C.
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (22) : 2440 - 2447
  • [7] Racial/Ethnic Differences in the Prevalence of Proteinuric and Nonproteinuric Diabetic Kidney Disease
    Bhalla, Vivek
    Zhao, Beinan
    Azar, Kristen M. J.
    Wang, Elsie J.
    Choi, Sarah
    Wong, Eric C.
    Fortmann, Stephen P.
    Palaniappan, Latha P.
    [J]. DIABETES CARE, 2013, 36 (05) : 1215 - 1221
  • [8] Non-albuminuric renal disease among subjects with advanced stages of chronic kidney failure related to type 2 diabetes mellitus
    Boronat, Mauro
    Garcia-Canton, Cesar
    Quevedo, Virginia
    Lorenzo, Dionisio L.
    Lopez-Rios, Laura
    Batista, Fatima
    Riano, Marta
    Saavedra, Pedro
    Checa, Maria D.
    [J]. RENAL FAILURE, 2014, 36 (02) : 166 - 170
  • [9] Budhiraja P, 2013, J Biomedical Science and Engineering, V6, P20, DOI 10.4236/jbise.2013.65A005
  • [10] Risk of Rapid Kidney Function Decline, All-Cause Mortality, and Major Cardiovascular Events in Nonalbuminuric Chronic Kidney Disease in Type 2 Diabetes
    Buyadaa, Oyunchimeg
    Magliano, Dianna J.
    Salim, Agus
    Koye, Digsu N.
    Shaw, Jonathan E.
    [J]. DIABETES CARE, 2020, 43 (01) : 122 - 129